Cephalexin and Adcirca drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cephalexin (cephalexin) and Adcirca (tadalafil). Common drug interactions include multiple allergies among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Cephalexin and Adcirca. It is created by eHealthMe based on reports of 83 people who take the same drugs from the FDA, and is updated regularly.

What is Cephalexin?

Cephalexin has active ingredients of cephalexin. It is often used in infection. eHealthMe is studying from 30,580 Cephalexin users. Check the latest studies of Cephalexin.

What is Adcirca?

Adcirca has active ingredients of tadalafil. It is often used in pulmonary hypertension. eHealthMe is studying from 54,957 Adcirca users. Check the latest studies of Adcirca.

On Jul, 12, 2026

83 people who take Cephalexin and Adcirca together, and have interactions are studied.

Cephalexin and Adcirca drug interactions.

What are the common drug interactions of Cephalexin and Adcirca, by gender? *:

female:

Multiple allergies (allergy to multiple agents)
Pallor
Pulmonary arterial hypertension (high blood pressure in the arteries of lungs)
Pulmonary mass
Rhinorrhoea (watery mucus discharge from the nose)
Tinnitus (a ringing in the ears)
Blood creatinine increased
Blood pressure increased
Catheter site pruritus (itching at the site)
Fall

male:

Pneumonia
Dyspnoea (difficult or laboured respiration)
Back pain
Blood albumin decreased
Blood alkaline phosphatase increased
Blood lactic acid increased
Chest discomfort
Confusional state
Coronary arterial stent insertion
Cough

What are the common drug interactions of Cephalexin and Adcirca, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Blood pressure increased
Cardiac arrest
Dizziness
Epistaxis (bleed from the nose)
Fatigue (feeling of tiredness)
Hypertension (high blood pressure)
Kidney infection
Loss of consciousness
Metapneumovirus infection (infection with human metapneumovirus)
Pallor

20-29:

n/a

30-39:

Acidosis (build-up of carbon dioxide in the blood)
Ascites (accumulation of fluid in the abdominal cavity)
Blood potassium increased
Cardiogenic shock (inadequate circulation of blood)
Cor pulmonale acute (rapid enlargement of the right ventricle of the heart)
Dyspnoea (difficult or laboured respiration)
Fluid overload (too much fluid in the blood)
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Haemoglobin decreased
Hyperkalaemia (damage to or disease of the kidney)

40-49:

Swelling face
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Diarrhoea
Tachycardia (a heart rate that exceeds the range of 100 beats/min)

50-59:

Infusion site infection
Infusion site mass
Infusion site oedema (swelling from excessive accumulation of watery fluid from infusion site)
Infusion site pain
Infusion site warmth
Injection site discharge
Lung transplant
Pyrexia (fever)
Rash
Viral infection

60+:

Dyspnoea (difficult or laboured respiration)
Headache (pain in head)
Fluid retention (an abnormal accumulation of fluid in the blood)
Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
Seasonal allergy (allergic condition due to certain season)
Abdominal pain upper
Back pain
Hypertension (high blood pressure)
Immunodeficiency
Insomnia (sleeplessness)

What are the existing conditions these people have? *

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 53 people, 63.86%

* Approximation only. Some reports may have incomplete information.

Do you take Cephalexin and Adcirca?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously